Sex-defined T-cell responses to cardiac self determine differential outcomes of murine dilated cardiomyopathy

American Journal of Pathology

Volumn 172, Issue 1, 2008, Pages 11-21

  Jane Wit, Daniel ^a,b   Altuntas, Cengiz Z ^a   Monti, Jennifer ^c   Johnson, Justin M ^a   Forsthuber, Thomas G ^b,d   Tuohy, Vincent K ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 2; MYOSIN HEAVY CHAIN ALPHA; P406 425 PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; T LYMPHOCYTE ACTIVATION;

EID: 38749141376     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070324     Document Type: Article

References (48)

1. Whitacre CC, Reingold SC, O'Looney PA: A gender gap in autoimmunity. Science 1999, 283:1277-1280
2. Whitacre CC: Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780
3. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, Offner H: Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004, 173:2227-2230
4. Liva SM, Voskuhl RR: Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 2001, 167:2060-2067
5. Enserink M: Women's health. The vanishing promises of hormone replacement. Science 2002, 297:325-326
6. Reddy J, Waldner H, Zhang X, Illes Z, Wucherpfennig KW, Sobel RA, Kuchroo VK: Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J Immunol 2005, 175:5591-5595
7. Huber SA: Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d. Med Microbiol Immunol 2005, 194:121-127
8. Frisancho-Kiss S, Nyland JF, Davis SE, Frisancho JA, Barrett MA, Rose NR, Fairweather D: Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Brain Res 2006, 1126:139-147
9. Smith SC, Allen PM: Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci USA 1992, 89:9131-9135
10. Donermeyer DL, Beisel KW, Allen PM, Smith SC: Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med 1995, 182:1291-1300
11. Leinwand LA: Sex is a potent modifier of the cardiovascular system. J Clin Invest 2003, 112:302-307
12. Jane-wit D, Yu M, Edling AE, Kataoka S, Johnson JM, Stull LB, Moravec CS, Tuohy VK: A novel class II-binding motif selects peptides that mediate organ-specific autoimmune disease in SWXJ, SJL/J, and SWR/J mice. J Immunol 2002, 169:6507-6514
13. Wynne J, Braunwald E: The cardiomyopathies and myocarditides. Heart Disease, vol 2. Edited by Braunwald E, Zipes DP, Libby P. New York, WB Saunders, 2001, pp 1751-1806
14. Stull LB, DiIulio NA, Yu M, McTiernan CF, Ratliff NB, Tuohy VK, Moravec CS: Alterations in cardiac function and gene expression during autoimmune myocarditis in mice. J Mol Cell Cardiol 2000, 32:2035-2049
15. Critchfield JM, Racke MK, Zuniga-Pflucker JC, Cannella B, Raine CS, Goverman J, Lenardo MJ: T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994, 263:1139-1143
16. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM: Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993, 362:758-761
17. Sakaguchi S: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562
18. DeSilva DR, Urdahl KB, Jenkins MK: Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol 1991, 147:3261-3267
19. Schwartz RH: T cell anergy. Annu Rev Immunol 2001, 21:305-334
20. Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, Griffith TS, Green DR, Schoenberger SP: CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005, 434:88-93
21. Sun JC, Bevan MJ: Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003, 300:339-342
22. Lesage S, Hartley SB, Akkaraju S, Wilson J, Townsend M, Goodnow CC: Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med 2002, 196:1175-1188
23. Kadokami T, McTiernan CF, Kubota T, Frye CS, Feldman AM: Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest 2000, 106:589-597
24. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240
25. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, Rose NR: Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 2001, 159:193-203
26. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132
27. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141
28. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238
29. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT: Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234
30. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189
31. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM: Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688
32. Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Barrett MA, Rose NR, Fairweather D: Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 2007, 178:6710-6714
33. Igarashi H, Kouro T, Yokota T, Comp PC, Kincade W: Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc Natl Acad Sci USA 2001, 98:15131-15136
34. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186
35. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H: Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res 2006, 84:370-378
36. Yang L, Hu Y, Hou Y: Effects of 17beta-estradiol on the maturation, nuclear factor kappa B p65 and functions of murine spleen CD11c-positive dendritic cells. Mol Immunol 2006, 43:357-366
37. Leitenberg D, Bottomly K: Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol 1999, 11:283-292
38. Gett AV, Sallusto F, Lanzavecchia A, Geginat J: T cell fitness determined by signal strength. Nat Immunol 2003, 4:355-360
39. Hayes SM, Li L, Love PE: TCR signal strength influences alphabeta/gammadelta lineage fate. Immunity 2005, 22:583-593
40. Salemi S, Caporossi AP, Boffa L, Longobardi MG, Barnaba V: HIV-gp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J Exp Med 1995, 181:2253-2257
41. Opdenakker G, Van Damme J: Cytokine-regulated proteases in autoimmune diseases. Immunol Today 1994, 15:103-107
42. Lanzavecchia A: How can cryptic epitopes trigger autoimmunity? J Exp Med 1995, 181:1945-1948
43. Grakoui A, Donermeyer DL, Kanagawa O, Murphy KM, Allen PM: TCR-independent pathways mediate the effects of antigen dose and altered peptide ligands on Th cell polarization. J Immunol 1999, 162:1923-1930
44. Yellayi S, Teuscher C, Woods JA, Welsh Jr TH, Tung KS, Nakai M, Rosenfeld CS, Lubahn DB, Cooke PS: Normal development of thymus in male and female mice requires estrogen/estrogen receptor-alpha signaling pathway. Endocrine 2000, 12:207-213
45. Staples JE, Gasiewicz TA, Fiore NC, Lubahn DB, Korach KS, Silverstone AE: Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 1999, 163:4168-4174
46. Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS: Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 2001, 163:49-62
47. Islander U, Erlandsson MC, Hasséus B, Jonsson CA, Ohlsson C, Gustafsson JA, Dahlgren U, Carlsten H: Influence of oestrogen receptor alpha and beta on the immune system in aged female mice. Immunology 2003, 110:149-157
48. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U: T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006, 203:2009-2019